Sheila Contapay-Tabilin, BSN, RN (510-428-3885 x 2611)<Solid Tumors |
Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine | NMTRC-014 | NCT02679144 Phase 2 | Beat Childhood Cancer
(BCC) | Anu Agrawal, MD | Anu Agrawal, MD (510-428-3885 x3539) |
Two-Part Study of TB-403 in Pediatric Subjects with Relapsed or Refractory Medulloblastoma, Neuroblastoma, Ewing Sarcoma or Alveolar Rhabdomyosarcoma | TB-403 | NCT02748135 Phase 1/2a | Beat Childhood Cancer
(BCC) and Oncurious NV | Jennifer Michlitsch, MD | Jennifer Michlitsch, MD (510-428-3885 x3264) |
STEM CELL TRANSP AND CELLULAR THERAPY |
---|
Oncology |
Role of KIR-favorably Mismatched Haploidentical Transplantation and KIR-polymorphisms in Determining Outcomes of Children with ALL/AML/MDS Undergoing Allogeneic Hematopoietic Cell Transplantation | ONC1401 | NCT02646839 Phase 1/2 | Pediatric Blood and Marrow Transplatn Consortium | Nahal Rose Lalefar, MD | Marci Moriarty, RN (510-428-3385 x5396) |
Oncology: Early Phase, Leukemia |
Pediatric and Young Adult Leukemia Adoptive Therapy. A Phase 1/2 Feasibility and Safety Study of CD19-CAR T Cell Immunotherapy for CD19+ Leukemia | PLAT-02 | NCT02028455 Phase 1/2 | Seattle Children's Hospital | Anu Agrawal, MD | Marci Moriarty, RN (510-428-3385 x5396) |